Low-dose colchicine in type 2 diabetes with microalbuminuria: A double-blind randomized clinical trial.

Yue WangXiaoqiong PengJinbo HuTing LuoZhihong WangQingfeng ChengMei MeiWenwen HeChuan PengLinqiang MaLilin GongShumin YangQi Fu Li

Published in: Journal of diabetes (2021)

In patients with T2D with microalbuminuria, low-dose colchicine effectively and safely lowered NRCI but did not prevent the incidence of overt nephropathy.

Keyphrases

low dose
type diabetes
high dose
risk factors
glycemic control
cardiovascular disease
insulin resistance
double blind
clinical trial
metabolic syndrome